Pharming Group N.V [PHARM] vs Ferrari Group PLC [FERGR] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pharming Group N.V wins in 6 metrics, Ferrari Group PLC wins in 12 metrics, with 0 ties. Ferrari Group PLC appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricPharming Group N.VFerrari Group PLCBetter
P/E Ratio (TTM)57.1512.74Ferrari Group PLC
Price-to-Book Ratio2.893.64Pharming Group N.V
Debt-to-Equity Ratio53.5717.86Ferrari Group PLC
PEG Ratio-101.1050.55Pharming Group N.V
EV/EBITDA26.6410.16Ferrari Group PLC
Profit Margin (TTM)-2.41%15.90%Ferrari Group PLC
Operating Margin (TTM)3.27%22.02%Ferrari Group PLC
EBITDA Margin (TTM)3.27%22.02%Ferrari Group PLC
Return on Equity-3.70%29.65%Ferrari Group PLC
Return on Assets (TTM)2.85%15.22%Ferrari Group PLC
Free Cash Flow (TTM)$-2.59M$53.69MFerrari Group PLC
Dividend YieldN/A2.57%N/A
1-Year Return39.73%5.65%Pharming Group N.V
Price-to-Sales Ratio (TTM)2.102.47Pharming Group N.V
Enterprise Value$603.34M$785.96MFerrari Group PLC
EV/Revenue Ratio2.072.25Pharming Group N.V
Gross Profit Margin (TTM)90.38%33.81%Pharming Group N.V
Revenue per Share (TTM)$1$5Ferrari Group PLC
Earnings per Share (Diluted)$-0.01$0.74Ferrari Group PLC
Beta (Stock Volatility)0.54N/AN/A
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends

Pharming Group N.V vs Ferrari Group PLC Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pharming Group N.V-0.59%0.00%18.60%17.24%21.43%6.25%
Ferrari Group PLC-0.85%-3.31%-0.95%16.88%3.89%3.89%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pharming Group N.V39.73%-11.30%-5.56%264.29%-36.65%-97.20%
Ferrari Group PLC5.65%5.65%5.65%5.65%5.65%5.65%

Performance & Financial Health Analysis: Pharming Group N.V vs Ferrari Group PLC

MetricPHARMFERGR
Market Information
Market Cap i€713.02M€860.96M
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i18,707,30734,024
90 Day Avg. Volume i9,474,28132,359
Last Close€1.02€9.35
52 Week Range€0.65 - €1.10€6.34 - €9.85
% from 52W High-7.30%-5.08%
All-Time High€459.55 (Jul 10, 2000)€9.85 (Jul 30, 2025)
% from All-Time High-99.78%-5.08%
Growth Metrics
Quarterly Revenue Growth0.26%0.04%
Quarterly Earnings Growth0.26%-0.07%
Financial Health
Profit Margin (TTM) i-0.02%0.16%
Operating Margin (TTM) i0.03%0.22%
Return on Equity (TTM) i-0.04%0.30%
Debt to Equity (MRQ) i53.5717.86
Cash & Liquidity
Book Value per Share (MRQ)€0.35€2.59
Cash per Share (MRQ)€0.18€1.37
Operating Cash Flow (TTM) i€26.66M€62.64M
Levered Free Cash Flow (TTM) i€19.91M€49.87M
Dividends
Last 12-Month Dividend Yield iN/A2.57%
Last 12-Month Dividend iN/A€0.23

Valuation & Enterprise Metrics Analysis: Pharming Group N.V vs Ferrari Group PLC

MetricPHARMFERGR
Price Ratios
P/E Ratio (TTM) i57.1512.74
Forward P/E i-101.1013.77
PEG Ratio i-101.1050.55
Price to Sales (TTM) i2.102.47
Price to Book (MRQ) i2.893.64
Market Capitalization
Market Capitalization i€713.02M€860.96M
Enterprise Value i€603.34M€785.96M
Enterprise Value Metrics
Enterprise to Revenue i2.072.25
Enterprise to EBITDA i26.6410.16
Risk & Other Metrics
Beta i0.54N/A
Book Value per Share (MRQ) i€0.35€2.59

Financial Statements Comparison: Pharming Group N.V vs Ferrari Group PLC

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PHARMFERGR
Revenue/Sales i€79.09M€90.89M
Cost of Goods Sold i€8.32M€60.16M
Gross Profit i€70.77M€30.73M
Research & Development i€21.14MN/A
Operating Income (EBIT) i€-7.43M€22.18M
EBITDA i€-4.11M€26.57M
Pre-Tax Income i€-11.79M€21.78M
Income Tax i€3.10M€4.01M
Net Income (Profit) i€-14.89M€17.77M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PHARMFERGR
Cash & Equivalents i€60.09M€108.33M
Total Current Assets i€214.11M€211.22M
Total Current Liabilities i€77.54M€73.89M
Long-Term Debt i€110.36M€21.50M
Total Shareholders Equity i€215.29M€190.78M
Retained Earnings i€-292.80M€91.57M
Property, Plant & Equipment i€24.23M€41.92M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PHARMFERGR
Operating Cash Flow i€2.07M€15.38M
Capital Expenditures iN/A€-2.10M
Free Cash Flow i€-56,000€15.29M
Debt Repayment i€-715,000€-6.15M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPHARMFERGR
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i18,707,30734,024
Average Daily Volume (90 Day) i9,474,28132,359
Shares Outstanding i680.31M91.30M
Float Shares i670.71M3.35M
% Held by Insiders i0.01%0.71%
% Held by Institutions i0.13%0.10%

Dividend Analysis & Yield Comparison: Pharming Group N.V vs Ferrari Group PLC

MetricPHARMFERGR
Last 12-Month Dividend iN/A€0.23
Last 12-Month Dividend Yield iN/A2.57%
3-Year Avg Annual Dividend iN/A€0.08
3-Year Avg Dividend Yield iN/A2.58%
3-Year Total Dividends iN/A€0.23
Ex-Dividend DateN/AJun 26, 2025